Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease

Objective:To observe whether baicalein have therapeutic value on diabetes mellitus (DM) with cerebral small vessel disease (CSVD) so as to explore the pathogenesis and therapy of the cognitive ability and behavioral function disorder caused by chronic cerebral ischemia and hypoxia.Methods:A total of...

Full description

Saved in:
Bibliographic Details
Main Authors: Li ZHOU, Zhengqi LU, Xiaoming YE, Wanxin YANG, Zhisheng WEI, Yi KONG, Xuming HUANG
Format: Article
Language:English
Published: Editorial Office of Rehabilitation Medicine 2018-02-01
Series:康复学报
Subjects:
Online Access:http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2018.01024
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841536994954444800
author Li ZHOU
Zhengqi LU
Xiaoming YE
Wanxin YANG
Zhisheng WEI
Yi KONG
Xuming HUANG
author_facet Li ZHOU
Zhengqi LU
Xiaoming YE
Wanxin YANG
Zhisheng WEI
Yi KONG
Xuming HUANG
author_sort Li ZHOU
collection DOAJ
description Objective:To observe whether baicalein have therapeutic value on diabetes mellitus (DM) with cerebral small vessel disease (CSVD) so as to explore the pathogenesis and therapy of the cognitive ability and behavioral function disorder caused by chronic cerebral ischemia and hypoxia.Methods:A total of thirty male SD rats were randomly divided into normal control group, model group and treatment group, 10 rats in each group. After the stable models of DM with CSVD were established, cognitive function scores of all rats were evaluated by Morris water maze test, and the levels of acetylcholine (Ach) and acetylcholinesterase (AchE) in brain were assessed to evaluate the protective effects of baicalein.Results:Morris water maze test showed that learning and memory function had been significantly impaired in rats of DM with CSVD since the 7th day of modeling. Spatial probe test founded that the times of crossing platform in the model group were significantly lower than those in the normal control group (<italic>P</italic>&lt;0.05). Compared with the normal control group, the Ach level in the brain homogenate of the model group reduced significantly (<italic>P</italic>&lt;0.05), while the AchE level increased significantly (<italic>P</italic>&lt;0.05). Compared with the model group, the Ach level in the brain homogenate of the treatment group increased significantly (<italic>P</italic>&lt;0.05). The HE staining sections illustrated a large number of active neurons were found in the control group, but loose spongiform degeneration of brain tissue, apoptosis and necrosis of neurons and karyopyknosis were detected in the model group. However, it showed that the learning and memory abilities in the treatment group had improved, while the brain tissue also had been protected.Conclusion:Baicalein has a protective effect on cognitive impairment in diabetes mellitus with cerebral small vessel disease, and it may be a new targeted therapy for this disease.
format Article
id doaj-art-b2bbcf67fb2e449a900cae2aba7591f6
institution Kabale University
issn 2096-0328
language English
publishDate 2018-02-01
publisher Editorial Office of Rehabilitation Medicine
record_format Article
series 康复学报
spelling doaj-art-b2bbcf67fb2e449a900cae2aba7591f62025-01-14T10:05:20ZengEditorial Office of Rehabilitation Medicine康复学报2096-03282018-02-0128243023126876Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel DiseaseLi ZHOUZhengqi LUXiaoming YEWanxin YANGZhisheng WEIYi KONGXuming HUANGObjective:To observe whether baicalein have therapeutic value on diabetes mellitus (DM) with cerebral small vessel disease (CSVD) so as to explore the pathogenesis and therapy of the cognitive ability and behavioral function disorder caused by chronic cerebral ischemia and hypoxia.Methods:A total of thirty male SD rats were randomly divided into normal control group, model group and treatment group, 10 rats in each group. After the stable models of DM with CSVD were established, cognitive function scores of all rats were evaluated by Morris water maze test, and the levels of acetylcholine (Ach) and acetylcholinesterase (AchE) in brain were assessed to evaluate the protective effects of baicalein.Results:Morris water maze test showed that learning and memory function had been significantly impaired in rats of DM with CSVD since the 7th day of modeling. Spatial probe test founded that the times of crossing platform in the model group were significantly lower than those in the normal control group (<italic>P</italic>&lt;0.05). Compared with the normal control group, the Ach level in the brain homogenate of the model group reduced significantly (<italic>P</italic>&lt;0.05), while the AchE level increased significantly (<italic>P</italic>&lt;0.05). Compared with the model group, the Ach level in the brain homogenate of the treatment group increased significantly (<italic>P</italic>&lt;0.05). The HE staining sections illustrated a large number of active neurons were found in the control group, but loose spongiform degeneration of brain tissue, apoptosis and necrosis of neurons and karyopyknosis were detected in the model group. However, it showed that the learning and memory abilities in the treatment group had improved, while the brain tissue also had been protected.Conclusion:Baicalein has a protective effect on cognitive impairment in diabetes mellitus with cerebral small vessel disease, and it may be a new targeted therapy for this disease.http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2018.01024small brain vascular diseasediabetescognitive declinebaicalein
spellingShingle Li ZHOU
Zhengqi LU
Xiaoming YE
Wanxin YANG
Zhisheng WEI
Yi KONG
Xuming HUANG
Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
康复学报
small brain vascular disease
diabetes
cognitive decline
baicalein
title Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
title_full Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
title_fullStr Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
title_full_unstemmed Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
title_short Effect of Baicalein on Cognitive Impairment in Diabetes Mellitus with Cerebral Small Vessel Disease
title_sort effect of baicalein on cognitive impairment in diabetes mellitus with cerebral small vessel disease
topic small brain vascular disease
diabetes
cognitive decline
baicalein
url http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2018.01024
work_keys_str_mv AT lizhou effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT zhengqilu effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT xiaomingye effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT wanxinyang effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT zhishengwei effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT yikong effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease
AT xuminghuang effectofbaicaleinoncognitiveimpairmentindiabetesmellituswithcerebralsmallvesseldisease